Literature DB >> 7800477

Kinetic and equilibrium binding studies of the human papillomavirus type-16 transcription regulatory protein E2 interacting with core enhancer elements.

C M Sanders1, N J Maitland.   

Abstract

The human papillomaviruses (HPVs) are a family of DNA viruses which cause benign tumours of the skin and mucosa that infrequently progress to malignant carcinoma. The E2 open reading frame of HPV is thought to encode a papillomavirus-specific transcription factor which also has a role in viral replication. The E2 proteins of all papillomaviruses studied to date have been shown to bind specifically to the common conserved sequence ACC(N)6GGT found at multiple locations in their genomes. In the case of HPV-16, a 'high risk' genital papillomavirus, the E2 protein is thought to negatively regulate expression of the major viral transforming genes E6 and E7, which have been directly implicated in the oncogenic process. However, little information exists concerning the relative or absolute affinities of the native HPV-16 protein for its palindromic recognition sequences; moreover, interpretation of any transcription or replication phenomena attributed to this protein is more complicated in the absence of such data. Here we describe the overexpression, purification and characterisation of the C-terminal 89 amino acids of the protein encompassing the DNA binding/dimerisation domain. We show that the recombinant protein purified from E.coli by a combination of non-group-specific chromatography steps retains high biological activity and is able to bind to all sites in the HPV-16 genome with high affinity (approximately 8 x 10(-11) M). In addition, kinetic studies show that the E2-DNA complexes are very stable, with half-lives ranging from 2.15 to greater than 240 min, and that nucleotides internal and external to the conserved palindrome appear to influence stability.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7800477      PMCID: PMC523753          DOI: 10.1093/nar/22.23.4890

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  43 in total

1.  The 68-kilodalton E1 protein of bovine papillomavirus is a DNA binding phosphoprotein which associates with the E2 transcriptional activator in vitro.

Authors:  I L Blitz; L A Laimins
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

2.  Cooperative activation of transcription by bovine papillomavirus type 1 E2 can occur over a large distance.

Authors:  F Thierry; N Dostatni; F Arnos; M Yaniv
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

Review 3.  Heterogeneity of the human papillomavirus group.

Authors:  E M de Villiers
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

4.  Trans activation by the bovine papillomavirus E2 protein in Saccharomyces cerevisiae.

Authors:  L C Morrissey; J Barsoum; E J Androphy
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

5.  The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element.

Authors:  B Gloss; H U Bernard
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs.

Authors:  J Choe; P Vaillancourt; A Stenlund; M Botchan
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

7.  The DNA-binding domain of HPV-16 E2 protein interaction with the viral enhancer: protein-induced DNA bending and role of the nonconserved core sequence in binding site affinity.

Authors:  C L Bedrosian; D Bastia
Journal:  Virology       Date:  1990-02       Impact factor: 3.616

8.  Phosphorylation sites of the E2 transcriptional regulatory proteins of bovine papillomavirus type 1.

Authors:  A A McBride; J B Bolen; P M Howley
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

9.  Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain.

Authors:  T H Haugen; L P Turek; F M Mercurio; T P Cripe; B J Olson; R D Anderson; D Seidl; M Karin; J Schiller
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

10.  Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.

Authors:  K Münger; B A Werness; N Dyson; W C Phelps; E Harlow; P M Howley
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  10 in total

1.  DNA tightens the dimeric DNA-binding domain of human papillomavirus E2 protein without changes in volume.

Authors:  L M Lima; D Foguel; J L Silva
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes.

Authors:  C Demeret; C Desaintes; M Yaniv; F Thierry
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

3.  Equilibrium dissociation and unfolding of the dimeric human papillomavirus strain-16 E2 DNA-binding domain.

Authors:  Y K Mok; G de Prat Gay; P J Butler; M Bycroft
Journal:  Protein Sci       Date:  1996-02       Impact factor: 6.725

4.  HPV-16 E2 gene disruption and sequence variation in CIN 3 lesions and invasive squamous cell carcinomas of the cervix: relation to numerical chromosome abnormalities.

Authors:  D A Graham; C S Herrington
Journal:  Mol Pathol       Date:  2000-08

5.  Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31.

Authors:  F Stubenrauch; H B Lim; L A Laimins
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein.

Authors:  G Steger; S Corbach
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  Anomalous DNA binding by E2 regulatory protein driven by spacer sequence TATA.

Authors:  Zhiqun Xi; Yongli Zhang; Rashmi S Hegde; Zippora Shakked; Donald M Crothers
Journal:  Nucleic Acids Res       Date:  2010-02-25       Impact factor: 16.971

8.  Orientation of a novel DNA binding site affects human papillomavirus-mediated transcription and replication.

Authors:  C D Newhouse; S J Silverstein
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

9.  Dimerization of the human papillomavirus type 16 E2 N terminus results in DNA looping within the upstream regulatory region.

Authors:  Elena E Hernandez-Ramon; Julie E Burns; Wenke Zhang; Hannah F Walker; Stephanie Allen; Alfred A Antson; Norman J Maitland
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

10.  Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics.

Authors:  Ignacio E Sánchez; Mariano Dellarole; Kevin Gaston; Gonzalo de Prat Gay
Journal:  Nucleic Acids Res       Date:  2007-12-15       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.